U.S. Drug Tariffs Spark Fears of Price Hikes and Supply Chaos 💊💸
New U.S. tariffs on imported drugs could raise prices and disrupt global supply chains, sparking industry backlash and patient concerns worldwide. 💊🌍
PharmaNews
Read More
Novo Nordisk Backs China’s Healthcare Push 🌏💊
Danish pharma giant Novo Nordisk praises China’s healthcare initiatives, expressing strong market confidence and highlighting opportunities in diabetes care. 🌍💊
Trump’s 250% Pharma Tariff Plan: What You Need to Know 💊🇺🇸
Trump proposes up to 250% tariffs on foreign-made pharmaceuticals, starting ‘small’ and escalating over time. New semiconductor tariffs also expected. 🌍💊
U.S. Drug Tariffs Spark Global Health Concerns 🌍💊
Experts warn new U.S. tariffs on drugs could drive up prices, disrupt global medical supply chains, and weaken crisis response systems. 🌍💊
China Pharma Chamber Slams U.S. Trade Tactics 💊🛡️
A Chinese healthcare trade group condemns U.S. ‘unilateral trade bullying,’ vows global collaboration to protect industry rights. 🌍💊
🌍 Cross-Border Healthcare Collaboration Vital, Says Sino BioPharm CEO
Sino BioPharm CEO Eric Tse urges global healthcare collaboration, citing tech partnerships and youth-driven innovation as keys to progress.
U.S. Congress Targets Chinese Pharma in ‘Bitter Pill’ Biosecure Act
The U.S. House passes the Biosecure Act, pushing pharma firms to cut ties with Chinese suppliers by 2032. What’s behind the move? 💊🇺🇸🇨🇳